Inventor · disambiguated record
Scott A. Hilderbrand
Also filed as: HILDERBRAND SCOTT · HILDERBRAND SCOTT A · HILDERBRAND SCOTT ALAN
16 granted patents·16 pending applications·107 citations·filing 2009–2025
92Inventor score
Files withIMMUNOGEN INC11DYNE THERAPEUTICS INC10MASSACHUSETTS GEN HOSPITAL5HILDERBRAND SCOTT A3GEN HOSPITAL CORP1
Top patents by PatentIndex Score
32 records- 0197US11931421B2Muscle targeting complexes and formulations for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2023·Granted Mar 19, 2024·26 cites·7 claims
- 0295US12128109B2Muscle targeting complexes and formulations for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·17 cites·28 claims
- 0395US10287256B2Selective sulfonation of benzodiazepine derivativesIMMUNOGEN INC·Filed 2017·Granted May 14, 2019·11 cites·19 claims
- 0493US10357574B2Optical sensor conjugates for detecting reactive oxygen and/or reactive nitrogen species in vivoMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Jul 23, 2019·31 cites·10 claims
- 0590US12440574B2Muscle targeting complexes and formulations for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2024·Granted Oct 14, 2025·0 cites·22 claims
- 0690US10494348B2Selective sulfonation of benzodiazepine derivativesIMMUNOGEN INC·Filed 2019·Granted Dec 3, 2019·3 cites·20 claims
- 0789US11833214B2Methods of preparing cell-binding agent-drug conjugatesIMMUNOGEN INC·Filed 2020·Granted Dec 5, 2023·3 cites·9 claims
- 0889US10611738B2Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactionsMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Apr 7, 2020·4 cites·14 claims
- 0988US2025367310A1Muscle targeting complexes and formulations for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1085US10822313B2Selective sulfonation of benzodiazepine derivativesIMMUNOGEN INC·Filed 2019·Granted Nov 3, 2020·1 cites·20 claims
- 1184US2025339553A1Muscle targeting complexes and formulations for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1283US8900549B2Compositions and methods for delivering a substance to a biological targetHILDERBRAND SCOTT A·Filed 2009·Granted Dec 2, 2014·7 cites·2 claims
- 1380US9902705B2Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactionsMASSACHUSETTS GEN HOSPITAL·Filed 2013·Granted Feb 27, 2018·2 cites·24 claims
- 1480US2023391733A1Selective sulfonation of benzodiazepine derivativesIMMUNOGEN INC·Filed 2022·Application pending·0 cites
- 1576US2024350652A1Methods of preventing methionine oxidation in immunoconjugatesIMMUNOGEN INC·Filed 2024·Application pending·0 cites
- 1672US11572349B2Selective sulfonation of benzodiazepine derivativesIMMUNOGEN INC·Filed 2020·Granted Feb 7, 2023·0 cites·20 claims
- 1771US2025057972A1Muscle targeting complexes and formulations for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1870US2024216521A1Methods of preparing cell-binding agent-drug conjugatesIMMUNOGEN INC·Filed 2023·Application pending·0 cites
- 1967US8916137B2Monofunctional carbocyanine dyes for in vivo and in vitro imagingHILDERBRAND SCOTT A·Filed 2009·Granted Dec 23, 2014·2 cites·6 claims
- 2067US2022202947A1Methods of preventing methionine oxidation in immunoconjugatesIMMUNOGEN INC·Filed 2021·Application pending·0 cites
- 2166US11208390B2Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactionsMASSACHUSETTS GEN HOSPITAL·Filed 2020·Granted Dec 28, 2021·0 cites·15 claims
- 2265US2025249117A1Dosing of muscle targeting complexes for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2361US2019111147A1Methods of preventing methionine oxidation in immunoconjugatesIMMUNOGEN INC·Filed 2018·Application pending·0 cites
- 2460US2025018050A1Dosing of muscle targeting complexes for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2556US2024100177A1Antibody-oligonucleotide complexes and uses thereofDYNE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2651US2023330562A1Methods of preparing protein-oligonucleotide complexesDYNE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2749US2013302246A1Compositions and methods for delivering a substance to a biological targetGEN HOSPITAL CORP·Filed 2013·Application pending·0 cites
- 2843US9636423B2Optical sensor conjugates for detecting reactive oxygen and/or reactive nitrogen species in vivoHILDERBRAND SCOTT A·Filed 2011·Granted May 2, 2017·0 cites·11 claims
- 2941US10179775B2Cyclooctenes for bioorthogonol reactionsMASSACHUSETTS GEN HOSPITAL·Filed 2015·Granted Jan 15, 2019·0 cites·24 claims
- 3037US2019038762A1Gcc-targeted antibody-drug conjugatesMILLENNIUM PHARM INC·Filed 2017·Application pending·0 cites
- 3136US2021299265A1Efficient process for preparing cell-binding agent-cytotoxic agent conjugatesIMMUNOGEN INC·Filed 2017·Application pending·0 cites
- 3235US2012121509A1Vital fluorochrome conjugates and methods of useJOSEPHSON LEE·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →